Colin Baigent

Research interests

Publications

• 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

  European Heart Journal · 2025 · 10.1093/eurheartj/ehaf190

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02074-8

• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00590-0

• COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31356-8

• 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

  European Heart Journal · 2019 · 10.1093/eurheartj/ehz467

• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

  European Heart Journal · 2019 · 10.1093/eurheartj/ehz455

• 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz405

• Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)31942-1

• Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2019 · 10.1016/j.kint.2019.02.022

• Interpretation of the evidence for the efficacy and safety of statin therapy

  The Lancet · 2016 · 10.1016/s0140-6736(16)31357-5

• Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

  The Lancet · 2014 · 10.1016/s0140-6736(14)60584-5

• Aspirin in Patients Undergoing Noncardiac Surgery

  New England Journal of Medicine · 2014 · 10.1056/nejmoa1401105

• 'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635-1701, doi: 10.1093/eurheartj/ehs092]

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs254

• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs092

• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  The Lancet · 2011 · 10.1016/s0140-6736(11)60739-3

• Antiplatelet Drugs

  CHEST Journal · 2008 · 10.1378/chest.08-0672

• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  BMJ · 2006 · 10.1136/bmj.332.7553.1302

• Low-Dose Aspirin for the Prevention of Atherothrombosis

  New England Journal of Medicine · 2005 · 10.1056/nejmra052717

• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  The Lancet · 2005 · 10.1016/s0140-6736(05)67394-1

• Cholesterol and the Risk of Renal Dysfunction in Apparently Healthy Men

  Journal of the American Society of Nephrology · 2003 · 10.1681/asn.v1482084

• Premature cardiovascular disease in chronic renal failure

  The Lancet · 2000 · 10.1016/s0140-6736(00)02456-9

• Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

  Circulation · 1998

• ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither

  BMJ · 1998 · 10.1136/bmj.316.7141.1337

• ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

  Ghent University Academic Bibliography (Ghent University) · 1995

• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  PubMed · 1988

Current projects

No projects listed.